Semaglutide, the active medication in Ozempic, works by making you feel full sooner and having that feeling last longer. No longer will you want to eat a full sandwich or three slices of pizza. You will find that you are done after half a sandwich or one slice. It’s that simple.
At Bala Better Health, we get our semaglutide from a US-based, state-supervised compounding pharmacy which is referred to as an “outsourcing facility”. They are safe and well regulated but the government.
The Drug Quality and Security Act, of 2013, section 503B, in the Federal Food, Drug, and Cosmetic Act established and regulates “outsourcing facilities”.
An outsourcing facility is overseen and inspected by the FDA, along with state regulators.
Compounding pharmacies must comply with section 503B and all current good manufacturing practice (CGMP) requirements.
Is Semaglutide generic?
As a shorthand, we refer to the with Semaglutide as “generic”. Often, ‘generic’ in the context of pharmaceuticals refers to a drug that is being manufactured after a name-brand drug has lost its patent protection.
That’s certainly not the case here. We refer to it as a ‘generic’ because:
An alternative way of saying the medication is not a name brand.
It is less confusing; nearly everyone is familiar with using ibuprofen in place of Motrin™
It has the same active ingredient whether it was created at a compounding pharmacy or at a large pharmaceutical company..
How can BBH supply brand-name drug?
Because the Semaglutide is in short supply, it was placed on the “FDA Shortage List”. This allows the compounding pharmacies permission to duplicate a commercially-sold medication and supply it to licensed physicians.
So what if semaglutide is removed from the shortage list?
The short answer is that we do not know. This will be determined by the FDA.
If you would like to learn more, come in to discuss it with our medical staff.
